Risk of Hepatic Failure After 16g + 12g Paracetamol Ingestion
This ingestion pattern (28g total over 48 hours) represents a repeated supratherapeutic overdose with substantial risk of severe hepatotoxicity and potential acute liver failure, particularly if treatment is delayed beyond 10 hours from the first ingestion.
Quantifying the Risk
The total dose of 28g substantially exceeds toxic thresholds. Based on guideline evidence, this scenario carries significant hepatotoxicity risk:
- For repeated supratherapeutic ingestions: The pattern described (16g in first 24h, 12g in next 24h) far exceeds the referral threshold of ≥10g in a single 24-hour period 1
- Severe hepatotoxicity rates in untreated or delayed-treatment cases historically approach 58% 1
- Mortality risk in delayed treatment (>10 hours) ranges from 5-27% depending on treatment timing 1
Critical Time-Dependent Factors
The risk of progression to hepatic failure is heavily time-dependent:
If NAC Started Early (<8-10 hours):
- Severe hepatotoxicity risk: 2.9-6.1% 1
- Mortality: essentially 0% 1
- This represents the critical therapeutic window
If NAC Started 10-16 hours:
- Severe hepatotoxicity risk: 29% 1
- Mortality increases significantly
If NAC Started 16-24 hours:
If NAC Started >24 hours:
- Risk substantially elevated, though NAC still provides benefit 1
Management Algorithm
Immediate actions regardless of presentation time:
Administer NAC immediately - do not wait for laboratory results in this dose range 1
- The Rumack-Matthew nomogram does NOT apply to repeated supratherapeutic ingestions 1
- Treatment should be empiric based on reported dose alone
Obtain baseline laboratories:
Continue NAC until:
- Paracetamol level undetectable
- Transaminases stable or declining
- INR normal
- Minimum 72 hours monitoring before discontinuation 3
Special Considerations for This Pattern
Repeated supratherapeutic ingestions have worse prognosis than single acute overdoses 1. Key concerns:
- Cannot risk-stratify using standard nomogram 1
- May have delayed peak paracetamol levels (up to 54 hours reported) 3
- Approximately 30% of acetaminophen overdose admissions involve this pattern 1
- 42-51% of acute liver failure cases in the US are acetaminophen-related 4
Pitfalls to Avoid
- Do not rely on normal transaminases in ED - hepatotoxicity may develop over subsequent hours 1
- Do not stop NAC prematurely - monitor for at least 72 hours after large overdoses 3
- Do not attempt nomogram-based risk stratification - this is a repeated ingestion pattern 1
- Consider psychiatric evaluation - 48% of cases are unintentional, often involving chronic pain and multiple preparations 4
Prognosis With Appropriate Treatment
With immediate NAC administration, transplant-free survival is approximately 65-71% 4. However, delayed presentation (>15 hours) is associated with liver damage in most untreated cases 5. The median ingested dose in acetaminophen-induced acute liver failure is 24g 4, making this 28g ingestion particularly concerning.
Level B recommendation: Administer NAC to patients with hepatic failure thought to be due to acetaminophen 1. Level C recommendation: Administer NAC to patients who have hepatotoxicity and suspected acetaminophen overdose, including repeated supratherapeutic ingestions 1.